News about Global Pharma

Omega Laboratories Teams Up with Cannabix Technologies for Marijuana Breath Detection

Omega Laboratories Teams Up with Cannabix Technologies for Marijuana Breath Detection

Omega Laboratories has entered into a strategic partnership with Cannabix Technologies Inc., a pioneer in cannabis breathalyzer technology.

Global Pharma | 18/05/2024 | By Aishwarya 361

Telo Genomics and Emery Pharma Announce Collaboration to Enhance Oncology Testing

Telo Genomics and Emery Pharma Announce Collaboration to Enhance Oncology Testing

This partnership aims to offer complementary cellular and molecular bioanalytical solutions for clinical research and development initiatives to their respective clients.

Global Pharma | 18/05/2024 | By Abha 631

SII Invests in IntegriMedical to Boost N-FIS Technology

SII Invests in IntegriMedical to Boost N-FIS Technology

Serum Institute of India (SII) has made a strategic investment in IntegriMedical, acquiring a 20 percent stake in the company, to advance Needle-Free Injection System technology.

Global Pharma | 18/05/2024 | By Aishwarya 606

Lupin Gets Approval from US FDA for Midostaurin Capsules

Lupin Gets Approval from US FDA for Midostaurin Capsules

Lupin has secured approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Midostaurin Capsules.

Global Pharma | 18/05/2024 | By Aishwarya 730

Olympus to Highlight EVIS X1 Endoscopy System and Colorectal Cancer Screening Solutions at Digestive Disease Week Annual Meeting

Olympus to Highlight EVIS X1 Endoscopy System and Colorectal Cancer Screening Solutions at Digestive Disease Week Annual Meeting

The EVIS X1 endoscopy system features imaging technologies designed to help physicians diagnose, treat and observe diseases and disorders of the upper and lower GI tract, including colorectal cancer.

Global Pharma | 17/05/2024 | By Manvi 409

Johnson & Johnson to Acquire Proteologix to Expand its Portfolio

Johnson & Johnson to Acquire Proteologix to Expand its Portfolio

Johnson & Johnson has signed a definitive agreement to acquire Proteologix, Inc. for USD 850 million in cash, with the potential for an additional milestone payment.

Global Pharma | 17/05/2024 | By Aishwarya 791

Bristol Myers Squibb Gets US FDA Approval for Breyanzi

Bristol Myers Squibb Gets US FDA Approval for Breyanzi

Bristol Myers Squibb has declared that US Food and Drug Administration (FDA) has granted accelerated approval for Breyanzi.

Global Pharma | 17/05/2024 | By Aishwarya 801

FX Shoulder Solutions Secures FDA Clearance for Full-Wedge Augmented Glenoid Baseplates

FX Shoulder Solutions Secures FDA Clearance for Full-Wedge Augmented Glenoid Baseplates

This clearance brings the total number of glenoid baseplate options to 18, providing a variety of solutions for surgeons addressing bone loss, defects, or complicated glenoid morphologies.

Global Pharma | 17/05/2024 | By Abha 745

FDA Approves Amgen's IMDELLTRA for Advanced Small Cell Lung Cancer

FDA Approves Amgen's IMDELLTRA for Advanced Small Cell Lung Cancer

The approval is based on the encouraging response rate and duration of response (DoR) observed in clinical studies, under the FDA's accelerated approval pathway.

Global Pharma | 17/05/2024 | By Abha 923

Granules India Records 2 Percent Growth in Revenue from Operations in Q4FY24

Granules India Records 2 Percent Growth in Revenue from Operations in Q4FY24

Granules India Ltd., has announced its financial results for the quarter and financial year ended March 31, 2024.

Global Pharma | 17/05/2024 | By Aishwarya 1274

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members